Evidence map›Paper›PMID 41081812›Full record

ArticleArchives of microbiology2025

Optimization and scalable production of Corynebacterium diphtheriae toxin using an animal component free medium: a pathway towards safer vaccine development.

Prashant R Chawla, Uma Addepally

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Prashant R ChawlaCenter of Biotechnology, University College of Engineering, Science and Technology, JNTUH, Kukatpally, Hyderabad, 500085, India.
Uma AddepallyCenter of Biotechnology, University College of Engineering, Science and Technology, JNTUH, Kukatpally, Hyderabad, 500085, India. vedavathi1@jntuh.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diphtheria is an infectious disease causing severe illness, particularly in children, which can be prevented by vaccination with diphtheria toxoid, a detoxified derivative form of diphtheria toxin. The present study aimed to overcome the limitations of traditional animal-derived medium and to enhance diphtheria toxin production by refining the various process parameters and iron concentration of semi-synthetic medium. The iron concentration in the medium was investigated in the range of 0.05 to 0.6 µg/mL, and an ideal concentration was found to be 0.4 µg/mL, where 221 ± 7.6 Lf/mL of DT was obtained. Response Surface Methodology was used to further optimize physical parameters such as pH, temperature, agitation speed, and concentration of inoculum. A central composite design comprising 30 experimental runs identified the best conditions as pH 7.2, temperature 35 °C, agitation speed 150 rpm, and 5.8% inoculum concentration yielding a maximum DT yield of 245 ± 5 Lf/mL. To validate scalability, a 5 L stirred-tank bioreactor was used to assess the influence of aeration and agitation on biomass and diphtheria toxin production were studied. At 600 rpm and 0.25 VVM, a maximum of 266 Lf/mL of diphtheria toxin was obtained. The biomass and toxin yields were adversely affected by higher aeration and agitation. This study highlights the significance of optimizing process parameters and establishing a scalable strategy for efficient production of diphtheria toxin using animal component-free medium.

Indexed as

Corynebacterium diphtheriaeCulture MediaDiphtheria ToxinVaccine DevelopmentBioreactorsDiphtheriaDiphtheria ToxoidHumansHydrogen-Ion ConcentrationIronTemperatureCulture MediaDiphtheria ToxinDiphtheria ToxoidIronDiphtheriaNZ amineOptimizationResponse surface methodScale-upSemi-synthetic mediumToxin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.